EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Down 38.7% in June

EUDA Health Holdings Limited (NASDAQ:EUDA) was the target of a significant drop in short interest in the month of June. As of June 30th, there was short interest totaling 3,202 shares, a drop of 38.7% from the June 15th total of 5,223 shares. Based on an average daily trading volume, of 5,978 shares, the short-interest ratio is currently 0.5 days. Approximately 0.1% of the shares of the company are short sold.

EUDA Health Stock Up 4.5%

NASDAQ:EUDA opened at $11.68 on Thursday. The company has a 50-day moving average of $15.07 and a 200-day moving average of $18.50. EUDA Health has a 52 week low of $5.26 and a 52 week high of $86.00.

EUDA Health (NASDAQ:EUDA) last posted its earnings results on Tuesday, May 5th. The company reported ($0.44) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.20) by $0.76. The business had revenue of $1.92 million during the quarter, compared to the consensus estimate of $3.90 million. Equities research analysts predict that EUDA Health will post 1.6 earnings per share for the current fiscal year.

Institutional Investors Weigh In On EUDA Health

An institutional investor recently bought a new position in EUDA Health stock. Jane Street Group LLC bought a new position in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned 0.07% of EUDA Health at the end of the most recent reporting period. Institutional investors own 4.35% of the company’s stock.

Wall Street Analysts Forecast Growth

EUDA has been the subject of several recent research reports. Zacks Research raised EUDA Health from a “strong sell” rating to a “hold” rating in a report on Friday, May 8th. Weiss Ratings cut EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research report on Friday, May 8th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, EUDA Health currently has an average rating of “Hold” and a consensus price target of $55.00.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.